Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Quotazioni in diretta
| Data | Ora | Fonte | Titolo |
|---|---|---|---|
| 10/5/2024 | 17:27 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 07/2/2024 | 18:36 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 07/2/2024 | 18:01 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 05/1/2024 | 16:48 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 04/1/2024 | 15:00 | EDGAR2 | Form 8-K - Current report |
| 04/1/2024 | 15:00 | GLOBE | XBiotech to Begin Constructing New R&D Facility on its.. |
| 14/11/2023 | 15:00 | GLOBE | Dr. Alan Kivitz to Chair XBiotech’s Natrunix Program in.. |
| 09/11/2023 | 20:41 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 26/9/2023 | 15:00 | GLOBE | XBiotech Announces Enrollment Completion of Phase I Clinical.. |
| 30/8/2023 | 15:00 | GLOBE | XBiotech Announces Enrollment Completion of Phase II,.. |
| 11/8/2023 | 17:18 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 08/8/2023 | 17:47 | GLOBE | XBiotech Announces First Patient Begins Novel Natrunix.. |
| Apertura: 7,33 | Min: 7,1204 | Max: 7,33 |
| Chiusura: 7,25 |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
|
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni |
|
ADVFN Network
|
| ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
| ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
| ADVFN France ADVFN US ADVFN Korea |
![Logo di Merit Circle [OLD] (MCUSDT).](/common/images/company/COIN_MCUUSD.png){kind=small}
